Effective with dates of service on and after October 1, 2021, and in accordance with the IngenioRx Pharmacy and Therapeutics (P&T) process, Anthem Blue Cross will update its drug lists that support commercial health plans.

 

  • Updates include changes to drug tiers and the removal of medications from the formulary.

 

  • Please note, this update does not apply to the Select Drug List and does not impact Medicaid and Medicare plans.

 

To ensure a smooth member transition and minimize costs, providers should review these changes and consider prescribing a drug on formulary or on a lower tier, if appropriate.

 

View a summary of changes here.  


1270-0821-PN-CA



Featured In:
August 2021 Anthem Blue Cross Provider News - California